To ensure preclinical batches are truly representative and de-risk the transition toward GMP, we perform comprehensive, fit-for-purpose characterisation using orthogonal analytical methods. All results are compiled into a structured data package with clear method descriptions, acceptance criteria where applicable, and trending across batches—supporting comparability, tech transfer, and later CMC/IMPD inputs.
